MICHELLE WELKER: Open Payments
NPI 1093104655 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 70 payments from 20 companies in 2025. Trend: 2023 $1,448 · 2024 $1,042 · 2025 $1,795
Food & beverage: $1,795
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 14 | $372 |
| Procept Biorobotics Corporation | 4 | $349 |
| Ferring Pharmaceuticals Inc. | 6 | $160 |
| ABBVIE INC. | 8 | $133 |
| Janssen Biotech, Inc. | 7 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Sumitomo Pharma America, Inc. | 4 | $92 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| PFIZER INC. | 3 | $68 |
| UROGEN PHARMA, INC. | 2 | $55 |
Products named: PROVENGE, AQUABEAM ROBOTIC SYSTEM, ADSTILADRIN, ERLEADA, PLUVICTO, BOTOX, XTANDI, GEMTESA.
Industry payments across MO — which companies pay providers there.
